TNF blockers and psilocybin.
5 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as TNF blocker · TNF inhibitor · TNF inhibitors · anti-TNF
01 What the evidence covers
Best evidence available per medication| 5 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to Z- Adalimumab · Humira, Amjevita, Cyltezo, Hyrimoz, Hadlima, Yusimry, Idacio, Yuflyma, Abrilada, SimlandiEvidence: No psilocybin data
Rheumatoid arthritis; Polyarticular juvenile idiopathic arthritis
Not studied with psilocybin; no linking mechanism is described. Also, it weakens the immune system.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Crohn's disease; Rheumatoid arthritis
Not studied with psilocybin; no linking mechanism is described. Also, it weakens the immune system.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Rheumatoid arthritis; Polyarticular juvenile idiopathic arthritis (2 years and older)
Not studied with psilocybin; no linking mechanism is described. Also, it weakens the immune system.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Rheumatoid arthritis (with methotrexate); Psoriatic arthritis
Not studied with psilocybin; no linking mechanism is described. Also, it weakens the immune system.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Crohn's disease (adults and children 6 years and older); Ulcerative colitis (adults and children 6 years and older)
Not studied with psilocybin; no linking mechanism is described. Also, it weakens the immune system.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
04 State rules
Official text governsNo provision names these medications or this group.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRecords reviewed 2026-11-09. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z